This lecture was supported by Grant Number 6H79FG000999-01M001 from SAMHSA. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of SAMHSA.  

About The Speaker

Paul Nestadt, MD is an assistant professor in the Department of Psychiatry and Behavioral Science at the Johns Hopkins School of Medicine, with a secondary appointment in the
Department of Mental Health at the Johns Hopkins Bloomberg School of Public Health. He serves as the co-director and supervising psychiatrist for the Johns Hopkins Anxiety Disorders Clinic, where he utilizes behavioral therapies such as cognitive behavioral therapy and exposure as well as psychopharmacology for anxiety disorders including PTSD, OCD, Panic, and Generalized Anxiety in patients from the US and internationally. He is an attending psychiatrist on the Motivated Behaviors Unit, an inpatient psychiatric ward specializing in the treatment of substance use disorders in the context of major psychiatric illness. Dr. Nestadt’s current research focus on practical risk factors for suicide, such as firearm and opioid access. His research is fueled by a fruitful partnership with the Office of the Chief Medical Examiner of Maryland, which supplies data for the development of machine learning algorithms utilized in the prediction of suicide risk. He has applied this expertise to the study of suicide in special populations including Native Americans, African Americans, and the opioid using population. His research is sponsored in part by the James Wah Center for Mood Disorders Research, the American Foundation for Suicide Prevention, and the National Institutes of Health.

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Paul Nestadt, MD, reports that he no relationships with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months. He will not discuss any products, services, or off-label uses in this presentation. This presentation was initially planned and recorded prior to January 1, 2023; therefore, the financial disclosure statement from the speaker reflects only the preceding 12 months, as was the standard at the time. This enduring activity was last reviewed for content validity on September 1, 2023. All conflicts have been mitigated through review.

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Todd Peters, MD, Elizabeth Ryznar, MD, MSc, Louis Marino, MD, Devi Bhuyan, PsyD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Stacey Garnett, RN, MSN, Stephanie M. Robinson, MSN, RN, PMH-BC, NPD-BC, NE-BC , Heather Billings, RN, Lisa Illum, MLIS, MEd, and Jennifer Tornabene.